PubRank

Bijan Eghtesad

Author PubWeight™ 67.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tolerogenic immunosuppression for organ transplantation. Lancet 2003 4.09
2 Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: a 5-year experience. Liver Transpl 2015 2.03
3 Near-total human face transplantation for a severely disfigured patient in the USA. Lancet 2009 1.97
4 Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl 2005 1.79
5 First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries. Plast Reconstr Surg 2010 1.70
6 Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique. Liver Transpl 2009 1.51
7 Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: an analysis of 10 patients. Liver Transpl 2015 1.49
8 Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation 2004 1.43
9 Three-dimensional print of a liver for preoperative planning in living donor liver transplantation. Liver Transpl 2013 1.39
10 MELD and prediction of post-liver transplantation survival. Liver Transpl 2006 1.33
11 Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl 2009 1.22
12 Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation 2003 1.18
13 Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 2002 1.16
14 Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis. Am J Physiol Endocrinol Metab 2012 1.12
15 Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 2006 1.12
16 Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism. Proc Natl Acad Sci U S A 2013 1.11
17 Dental health status of liver transplant candidates. Liver Transpl 2007 1.05
18 Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl 2012 1.03
19 A survey of dental care protocols among US organ transplant centers. Clin Transplant 2005 1.02
20 Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005 1.02
21 Immunosuppression in liver transplantation: beyond calcineurin inhibitors. Liver Transpl 2005 0.98
22 Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004 0.98
23 Liver transplantation in patients with HIV infection. Liver Transpl 2004 0.97
24 Diagnosis and treatment of intracardiac thrombosis during orthotopic liver transplantation. Anesth Analg 2004 0.94
25 Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation 2004 0.94
26 Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clin Transplant 2010 0.93
27 Dental management of the (solid) organ transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 0.92
28 Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation 2011 0.92
29 Acetaminophen: old drug, new warnings. Cleve Clin J Med 2010 0.89
30 "Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not arterial siphon. Liver Transpl 2008 0.89
31 Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature. Liver Transpl 2006 0.89
32 Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography. AJR Am J Roentgenol 2002 0.89
33 Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol 2003 0.89
34 Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol 2014 0.89
35 Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl 2003 0.88
36 Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy. Am J Surg Pathol 2006 0.88
37 Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria. Liver Transpl 2009 0.87
38 Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation. Transplantation 2005 0.87
39 Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplant. Transfusion 2004 0.86
40 Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel. Liver Transpl 2007 0.86
41 Expanding the donor pool: safe transplantation of a cadaveric liver allograft with a 10 cm cavernous hemangioma--a case report. Liver Transpl 2006 0.86
42 Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl 2011 0.85
43 Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients. Liver Transpl 2009 0.85
44 Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients? Surgery 2010 0.83
45 Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. Liver Transpl 2002 0.81
46 Rapid resolution of GVHD after orthotopic liver transplantation in a patient treated with alefacept. Blood 2009 0.81
47 Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function. Liver Transpl 2008 0.81
48 Surgical resection versus liver transplant for patients with hepatocellular carcinoma. Cochrane Database Syst Rev 2013 0.80
49 Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation. HPB (Oxford) 2011 0.80
50 Hepatic blood flow plays an important role in ischemia-reperfusion injury. Liver Transpl 2011 0.80
51 The Cleveland Clinic FACES Score: a preliminary assessment tool for identifying the optimal face transplant candidate. J Craniofac Surg 2009 0.79
52 Cruveilhier-Baumgarten disease in a patient with Turner syndrome: case report of a rare indication for liver transplantation. Liver Transpl 2008 0.79
53 Isolated right hepatic vein obstruction after piggyback liver transplantation. Liver Transpl 2006 0.79
54 Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation. Liver Transpl 2015 0.79
55 Impact of pretransplant rifaximin therapy on early post-liver transplant infections. Liver Transpl 2014 0.78
56 Role of tissue expanders in patients with loss of abdominal domain awaiting intestinal transplantation. Transpl Int 2013 0.78
57 Preservation solutions in liver transplantation: what are the options? Liver Transpl 2006 0.78
58 Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. Hepatobiliary Pancreat Dis Int 2013 0.77
59 Predicting the discharge status after liver transplantation at a single center: a new approach for a new era. Liver Transpl 2012 0.77
60 Triple-phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during liver transplantation. Liver Transpl 2008 0.77
61 Cardiovascular risk factors and cardiac disorders in long-term survivors of pediatric liver transplantation. Pediatr Transplant 2014 0.77
62 Sofosbuvir/Ledipasvir Without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence After Liver Transplantation: Two-Center Experience. Transplantation 2017 0.76
63 Reversal of protein-losing enteropathy after liver transplantation in a child with idiopathic familial neonatal hepatitis. Liver Transpl 2009 0.76
64 Role of vasodilation during normothermic machine perfusion of DCD porcine livers. Int J Artif Organs 2014 0.75
65 Sialadenosis in patients with advanced liver disease. Head Neck Pathol 2009 0.75
66 Extended follow-up of extended right lobe living donors: when is enough enough? Liver Transpl 2006 0.75
67 Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. HPB (Oxford) 2012 0.75
68 Future prospects in immunosuppression for liver transplantation. Liver Transpl 2011 0.75
69 Use of 3-dimensional imaging reconstruction in the treatment of advanced intra-abdominal desmoid tumors. Surgery 2011 0.75
70 The successful use of telaprevir to treat hepatitis C recurrence after liver transplantation in an HIV co-infected patient. Transplantation 2014 0.75
71 Too Much, Too Little, or Just Right? The Importance of Allograft Portal Flow in Deceased Donor Liver Transplantation. Transplantation 2019 0.75
72 Accuracy of Noninvasive Fibrosis Scores in Predicting the Presence of Fibrosis in Patients after Liver Transplantation. Exp Clin Transplant 2017 0.75
73 Sequential split liver followed by isolated intestinal transplant: the "liver-first" approach: report of a case. Transplantation 2014 0.75
74 Recurrent upper gastrointestinal bleeding masquerading as gastric variceal bleeding on endoscopy after liver transplantation. Liver Transpl 2013 0.75
75 Liver transplantation at Cleveland Clinic. Clin Transpl 2010 0.75
76 Spur cell anemia as a cause of unconjugated hyperbilirubinemia after liver transplantation and its resolution after retransplantation. Liver Transpl 2011 0.75